BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6437388)

  • 1. The inhibition of platelet cyclo-oxygenase by aspirin is associated with the acetylation of a 72kDa polypeptide in the intracellular membranes.
    Hack N; Carey F; Crawford N
    Biochem J; 1984 Oct; 223(1):105-11. PubMed ID: 6437388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
    Roth GJ; Majerus PW
    J Clin Invest; 1975 Sep; 56(3):624-32. PubMed ID: 1159076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of sheep platelet cyclo-oxygenase. Acetylation by aspirin prevents haemin binding to the enzyme.
    Boopathy R; Balasubramanian AS
    Biochem J; 1986 Oct; 239(2):371-7. PubMed ID: 3101664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation of prostaglandin synthase by aspirin.
    Roth GJ; Stanford N; Majerus PW
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3073-6. PubMed ID: 810797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes.
    Carey F; Menashi S; Crawford N
    Biochem J; 1982 Jun; 204(3):847-51. PubMed ID: 6812567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
    Cerletti C
    Int J Tissue React; 1985; 7(4):309-12. PubMed ID: 3934097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
    Preston FE; Greaves M; Jackson CA; Stoddard CJ
    Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin.
    Rao GH; Johnson GJ; Reddy RK; White JG
    Prostaglandins; 1981 Nov; 22(5):761-72. PubMed ID: 6799989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of cyclo-oxygenase in human blood platelets by carbamate insecticides.
    Krug HF; Hamm U; Berndt J
    Biochem J; 1988 Feb; 250(1):103-10. PubMed ID: 3128272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from "in vivo" drug interaction studies in rats.
    Cerletti C; Livio M; De Gaetano G
    Biochim Biophys Acta; 1982 Jan; 714(1):122-8. PubMed ID: 6799004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites.
    Rotilio D; Joseph D; Hatmi M; Vargaftig BB
    Eur J Pharmacol; 1984 Jan; 97(3-4):197-208. PubMed ID: 6423393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities.
    Cerletti C; Livio M; Doni MG; De Gaetano G
    Biochim Biophys Acta; 1983 Aug; 759(1-2):125-7. PubMed ID: 6411131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin intolerance: unaltered susceptibility of platelet cyclo-oxygenase to inhibition by aspirin in vitro.
    Patrono C; Ciabattoni G; Venuti A; Pugliese F; Schiavino D; Patriarca G
    J Allergy Clin Immunol; 1978 Nov; 62(5):271-5. PubMed ID: 100540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.
    Ouellet M; Riendeau D; Percival MD
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14583-8. PubMed ID: 11717412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin.
    Stanford N; Roth GJ; Shen TY; Majerus PW
    Prostaglandins; 1977 Apr; 13(4):669-75. PubMed ID: 404672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylation of erythrocytic membrane peptides by aspirin.
    Green FA; Jung CY
    Transfusion; 1981; 21(1):55-8. PubMed ID: 7466908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of hepatic and extrahepatic metabolism of aspirin in selective inhibition of platelet cyclooxygenase.
    Roberts MS; Cossum PA; Kilpatrick D
    N Engl J Med; 1985 May; 312(21):1388-9. PubMed ID: 3921841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.